ARMP
Armata Pharmaceuticals Inc
3.60$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +24.7% | -36.8% | -100.0% | – | -58.5% | -60.2% | +341.8% | -46.6% | -6.4% | -27.3% | +218.1% | – | |
| – | +32.6% | +8.2% | -0.6% | -0.6% | +21.4% | -0.8% | -2.9% | +1.1% | +13.0% | +9.3% | +29.3% | – | |
| – | +23.0% | -47.4% | -148.5% | – | -67.9% | -86.7% | +1,481.6% | -56.2% | -15.5% | -50.2% | +478.0% | – | |
| – | -0.6% | +1.1% | +5.7% | +11.9% | -10.9% | -35.8% | +17.8% | -8.9% | +4.2% | +0.7% | +24.1% | – | |
| – | -11.3% | 0.0% | +8.2% | -5.7% | +2.4% | -2.1% | -19.5% | +18.8% | +10.1% | +1.1% | +51.2% | – | |
| – | -4.6% | +0.6% | +6.6% | +7.0% | -8.2% | -27.1% | +4.1% | -10.1% | +77.8% | -34.0% | +34.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +23.3% | +25.5% | +49.3% | +7.5% | +12.2% | +9.8% | +5.7% | +14.1% | +11.2% | +15.0% | +19.3% | – | |
| – | – | – | – | -161.0% | – | -351.2% | – | – | – | – | – | – | |
| – | – | -98.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -161.0% | – | -351.2% | – | – | – | – | – | – | |
| – | – | – | – | -118.7% | – | -140.8% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.